| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/03/2008 | WO2008001053A1 Treatment and/or prevention of pain using polyether polyols |
| 01/03/2008 | WO2008000818A1 Fluorinated indoleamides useful as ligands of the orl-1 receptor |
| 01/03/2008 | WO2008000777A2 Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use |
| 01/03/2008 | WO2008000744A2 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor |
| 01/03/2008 | WO2008000743A2 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists |
| 01/03/2008 | WO2008000669A1 Improving tolerance to anti-inflammatories |
| 01/03/2008 | WO2008000495A1 Use of 5-ht7 receptor agonists for the treatment of pain |
| 01/03/2008 | WO2008000410A1 Cxcr2 inhibitors |
| 01/03/2008 | WO2008000409A1 New cxcr2 inhibitors |
| 01/03/2008 | WO2008000408A1 Cxcr2 antagonists |
| 01/03/2008 | WO2008000042A1 Methods for the preparation of biologically active compounds in nanoparticulate form |
| 01/03/2008 | WO2006113942A3 Method of inhibiting cathepsin activity |
| 01/03/2008 | US20080004341 Immunotherapeutic Agent |
| 01/03/2008 | US20080004316 Novel aminopyridine derivatives as mGluR5 antagonists |
| 01/03/2008 | US20080004306 Compositions and methods for modulating gated ion channels |
| 01/03/2008 | US20080004278 (1-phenyl-5-propyl-1H-pyrazol-4-yl)-(3-amino-N-cyclopropyl-4-methyl-benzamide)-amine; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
| 01/03/2008 | US20080004277 Triazole compounds that modulate HSP90 activity |
| 01/03/2008 | US20080004258 such as [2-(3,4-Dichloro-phenoxy)-5-(4-morpholin-4-yl-but-1-ynyl)-benzyl]-methyl-amine, used as H3 receptor and/or serotonin transporter modulators useful in the treatment of cognitive, sleep and psychological disorders |
| 01/03/2008 | US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor |
| 01/03/2008 | US20080004246 Transporter enhanced corticosteroid activity |
| 01/03/2008 | US20080004220 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 01/03/2008 | US20080003675 Methods and compositions for identifying morphogen analogs |
| 01/03/2008 | US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 01/03/2008 | US20080003276 Glucocoricoid is an amphipathic weak acid or base such as methylprednisolone sodium hemisuccinate encapsulated in a liposome; treating rheumatoid arthritis or other autoimmune disease, provided they are not neurodegenerative disorders |
| 01/03/2008 | US20080003267 Pharmaceutical Composition |
| 01/03/2008 | US20080003219 Delivery of an ocular agent |
| 01/03/2008 | DE3890998B4 Neutrophilenaktivierungsfaktor, Verfahren zu seiner Herstellung und ihn enthaltende pharmazeutische Zusammensetzung Neutrophilenaktivierungsfaktor, process for its preparation and pharmaceutical composition containing it |
| 01/03/2008 | CA2657973A1 Therapeutic compounds |
| 01/03/2008 | CA2656159A1 Pyridylisoxazole derivatives |
| 01/03/2008 | CA2656150A1 New cxcr2 inhibitors |
| 01/03/2008 | CA2655999A1 Treating agent of inflammatory bowel disease |
| 01/03/2008 | CA2654371A1 Therapeutic compounds |
| 01/03/2008 | CA2653384A1 Methods for the preparation of biologically active compounds in nanoparticulate form |
| 01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/02/2008 | EP1873154A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF |
| 01/02/2008 | EP1873150A1 Fluorinated indoleamides useful as ligands of the ORL-1 receptor |
| 01/02/2008 | EP1873141A1 Calcium bis[2s)-3-[3-(2s)-3-(4-chloro-2-cyanophenoxy)-2- fluoropropoxy¨phenyl]-2-isopropoxypropionate] and intermediate thereof |
| 01/02/2008 | EP1872786A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 01/02/2008 | EP1871773A1 N-[3-(1-amino-5,6,7,8-tetrahydro-2,4,4b-triazafluoren-9-yl)-phenyl]benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 01/02/2008 | EP1871416A2 Methods for treating osteoarthitis pain by administering a nerve growth factor antagonist and compositions containing the same |
| 01/02/2008 | EP1871401A1 Use of lactobacillus rhamnosus gg for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant |
| 01/02/2008 | EP1871383A2 Device and methods for treating paranasal sinus conditions |
| 01/02/2008 | EP1871372A1 Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain |
| 01/02/2008 | EP1871367A2 Compounds for treating inflammatory and demyelinating diseases |
| 01/02/2008 | EP1871365A2 Methods for treating diseases through inhibition the function of molecular chaperones such as protein disulfide isomerases , pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
| 01/02/2008 | EP1871360A1 New anti-inflammatory compounds |
| 01/02/2008 | EP1750700B1 Liquid preparation for veterinary medicine, method for the production thereof, and use of the same |
| 01/02/2008 | EP1548027B1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 01/02/2008 | EP1539731B1 Novel compounds |
| 01/02/2008 | EP1537069B1 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 01/02/2008 | EP1534304B1 An analgesic agent for newborn or fetal subjects |
| 01/02/2008 | EP1465663B1 Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent |
| 01/02/2008 | EP1465614B1 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 01/02/2008 | EP1443942B1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonate, a cox-2 inhibitor and a taxol |
| 01/02/2008 | EP1435986B1 Igf-binding protein-derived peptide |
| 01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
| 01/02/2008 | EP1272161B1 Lipid-based drug delivery systems against parasitic infections |
| 01/02/2008 | EP1254130B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 01/02/2008 | EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/02/2008 | EP1121116B1 Sustained release pharmaceutical composition of fluvastatin |
| 01/02/2008 | CN101098706A Anti-inflammatory extract and agent and method for the production thereof |
| 01/02/2008 | CN101098687A Method of modulating b cell functioning |
| 01/02/2008 | CN101096368A Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/02/2008 | CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/02/2008 | CN101095927A Medicine for treating rheumatism or postpartum rheumatism |
| 01/02/2008 | CN101095889A Plaster for treating ache and method for preparing the same |
| 01/02/2008 | CN101095845A Century health preserving magical wine |
| 01/02/2008 | CN101095843A Pills for treating rheumatism and strengthening muscle |
| 01/02/2008 | CN101095761A Chinese traditional medicine for treating appendicitis and method for preparing the same |
| 01/02/2008 | CN101095730A Medicine for treating rheumatism atrophic arthritis |
| 01/02/2008 | CN101095729A Medicine for treating lumbar intervertebral disc protrusion |
| 01/02/2008 | CN101095705A Extract of the Chinese traditional medicine of fruits of Ailanthus altissima and the preparation technics and the use thereof |
| 01/02/2008 | CN101095677A Application of sophocarpine and the medicine salt thereof in the preparing of the medicine for increasing interferon |
| 01/02/2008 | CN101095671A Iguratimod oral double-layer sustained-release preparation |
| 01/02/2008 | CN101095670A Luteolin phospholipid complexes and method for preparing the same and application thereof |
| 01/02/2008 | CN101095669A Osthole phospholipid complexes and method for preparing the same and application thereof |
| 01/02/2008 | CN101095664A Phosphatide compound of resveratrol compounds and method for preparing the same and the application thereof |
| 01/02/2008 | CN100358920C Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
| 01/02/2008 | CN100358919C Mammal prolactin variants |
| 01/02/2008 | CN100358899C Platelet activation factor resisting compound |
| 01/02/2008 | CN100358892C 7-oxo pyridopyrimidines |
| 01/02/2008 | CN100358878C Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 01/02/2008 | CN100358869C Carbamate caspase inhibitors and uses thereof |
| 01/02/2008 | CN100358595C Safety shield system for prefilled syringe |
| 01/02/2008 | CN100358584C Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
| 01/02/2008 | CN100358580C Pharmaceutical compositions |
| 01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
| 01/02/2008 | CN100358554C Chinese medicinal capsules for disinfecting and relieving toxicity and their preparation |
| 01/02/2008 | CN100358532C Total flavone of citrus grandis osbeckvar tomentosa hort peridium, and its extracting method and use |
| 01/02/2008 | CN100358498C Gentongping dripping pill for treating wind-cold channel blocking and its preparing method |
| 01/02/2008 | CN100358494C Inhalation system |
| 01/01/2008 | US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 01/01/2008 | US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors |
| 01/01/2008 | US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| 01/01/2008 | US7314877 Benzofuran derivative |
| 01/01/2008 | US7314876 Administering to mammals nitrogen compounds, as mitogen activated kinase inhibitors, for prophylaxis asthma, respiratory system disorders, graft versus host disease, atherosclerosis and arthritis |
| 01/01/2008 | US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents |
| 01/01/2008 | US7314633 Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof |